Cite
HARVARD Citation
Aletaha, D. et al. (2017). Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study. Lancet. 389 (10075), pp. 1206-1217. [Online].